1. Home
  2. RDFN vs PLSE Comparison

RDFN vs PLSE Comparison

Compare RDFN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDFN
  • PLSE
  • Stock Information
  • Founded
  • RDFN 2002
  • PLSE 2014
  • Country
  • RDFN United States
  • PLSE United States
  • Employees
  • RDFN N/A
  • PLSE N/A
  • Industry
  • RDFN Real Estate
  • PLSE Medical/Dental Instruments
  • Sector
  • RDFN Finance
  • PLSE Health Care
  • Exchange
  • RDFN Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • RDFN 991.8M
  • PLSE 1.0B
  • IPO Year
  • RDFN 2017
  • PLSE 2016
  • Fundamental
  • Price
  • RDFN $9.16
  • PLSE $17.68
  • Analyst Decision
  • RDFN Hold
  • PLSE
  • Analyst Count
  • RDFN 11
  • PLSE 0
  • Target Price
  • RDFN $9.23
  • PLSE N/A
  • AVG Volume (30 Days)
  • RDFN 6.4M
  • PLSE 195.0K
  • Earning Date
  • RDFN 11-07-2024
  • PLSE 10-30-2024
  • Dividend Yield
  • RDFN N/A
  • PLSE N/A
  • EPS Growth
  • RDFN N/A
  • PLSE N/A
  • EPS
  • RDFN N/A
  • PLSE N/A
  • Revenue
  • RDFN $1,016,774,000.00
  • PLSE N/A
  • Revenue This Year
  • RDFN $8.63
  • PLSE N/A
  • Revenue Next Year
  • RDFN $10.93
  • PLSE N/A
  • P/E Ratio
  • RDFN N/A
  • PLSE N/A
  • Revenue Growth
  • RDFN 3.70
  • PLSE N/A
  • 52 Week Low
  • RDFN $5.10
  • PLSE $6.60
  • 52 Week High
  • RDFN $15.29
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • RDFN 46.23
  • PLSE 52.89
  • Support Level
  • RDFN $7.76
  • PLSE $15.62
  • Resistance Level
  • RDFN $11.88
  • PLSE $17.20
  • Average True Range (ATR)
  • RDFN 0.67
  • PLSE 1.27
  • MACD
  • RDFN -0.09
  • PLSE -0.07
  • Stochastic Oscillator
  • RDFN 33.98
  • PLSE 50.90

About RDFN Redfin Corporation

Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: